相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication
Yusaku Kajihara et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker
Hitomi Yamasaki et al.
XENOBIOTICA (2017)
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication
Soichiro Sue et al.
INTERNAL MEDICINE (2017)
Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
Kouichi Sakurai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial
Masafumi Maruyama et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
Masatsugu Okuyama et al.
DIGESTION (2017)
Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis
Shintaro Hoshino et al.
DIGESTION (2017)
Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
K. Ashida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype
T. Kagami et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy
Sho Suzuki et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis
Yiqiao Xin et al.
BMC GASTROENTEROLOGY (2016)
Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan
Mitsushige Sugimoto et al.
DIGESTION (2016)
Trends in Gastrointestinal Diseases in Japan Preface
Yasuhisa Shinomura
DIGESTION (2016)
Key Issues Associated with Helicobacter pylori Eradication
Takashi Kawai et al.
DIGESTION (2016)
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori
Masahiro Tsujimae et al.
DIGESTION (2016)
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
Kazunari Murakami et al.
GUT (2016)
Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypes
Tadayoshi Okimoto et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2016)
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice
Satoki Shichijo et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
A novel potassium-competitive acid blocker improves the efficacy of clarithromycin-containing 7-day triple therapy against Helicobacter pylori
Journal of Gastrointestinal and Liver Diseases (2016)
Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori
Satoshi Shinozaki et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2016)
Antimicrobial Resistance and Characteristics of Eradication Therapy of Helicobacter pylori in Japan: A Multi-Generational Comparison
Takuma Okamura et al.
HELICOBACTER (2014)
A new approach for elimination of gastric cancer deaths in Japan
Masahiro Asaka
INTERNATIONAL JOURNAL OF CANCER (2013)
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
Luigi Gatta et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin
E. A. Marcus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
A. G. McNicholl et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner et al.
GUT (2012)
A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan
Toshio Fujioka et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Helicobacter pylori eradication therapy
Hidekazu Suzuki et al.
FUTURE MICROBIOLOGY (2010)
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
Masahiro Asaka et al.
HELICOBACTER (2010)
Helicobacter pylori Infection
Kenneth E. L. McColl
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer:: an open-label, randomised controlled trial
Kazutoshi Fukase et al.
LANCET (2008)
New concepts of resistance in the treatment of Helicobacter pylori infections
David Y. Graham et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005
Intetsu Kobayashi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Helicobacter pylori and antibiotic resistance
Francis Megraud
GUT (2007)
American college of gastroenterology guideline on the management of Helicobacter pylori infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H-pylori
T. Furuta et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Medical progress:: Helicobacter pylori infection
S Suerbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
